Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Jeurissen, F.J.F.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(4)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(3)
+
-
Creation Date
2019
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Author
Jeurissen, F.J.F.
(4)
+
-
Baars, A.
(2)
+
-
Beijnen, J.H.
(2)
+
-
Cats, A.
(2)
+
-
Creemers, G.J.
(2)
+
-
Dezentje, V.O.
(2)
+
-
Droogendijk, H.J.
(2)
+
-
Frederix, G.W.J.
(2)
+
-
Gelderblom, H.
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Hamberg, P.
(2)
+
-
Henricks, L.M.
(2)
+
-
Imholz, A.L.T.
(2)
+
-
Jansen, R.L.H.
(2)
+
-
Kienhuis, E.
(2)
+
-
Koopman, M.
(2)
+
-
Kuilenburg, A.B.P. van
(2)
+
-
Lunenburg, C.A.T.C.
(2)
+
-
Man, F.M. de
(2)
+
-
Mandigers, C.M.P.W.
(2)
+
-
Mathijssen, R.H.J.
(2)
+
-
Meulendijks, D.
(2)
+
-
Nieboer, P.
(2)
+
-
Poel, M.H.W. van de
(2)
+
-
Portielje, J.E.A.
(2)
+
-
Rosing, H.
(2)
+
-
Schaik, R.H.N. van
(2)
+
-
Schellens, J.H.M.
(2)
+
-
Slingerland, M.
(2)
+
-
Swen, J.J.
(2)
+
-
Tije, A.J. ten
(2)
+
-
Werkhoven, E. van
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
Methotrexate plus or minus cetuximab as first-line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib-randomized phase II study Commence
PEG tube dependency after prophylactic placement in 209 head and neck cancer patients treated with chemoradiotherapy or radiation with cetuximab
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis